5-Amino-1MQ vs Efinopegdutide

Head-to-head comparison of 5-Amino-1MQ (5-Amino-1-methylquinolinium) and Efinopegdutide (Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

Property5-Amino-1MQEfinopegdutide
CategoryWeight ManagementWeight Management
Full Name5-Amino-1-methylquinoliniumEfinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist
Molecular Weight178.23 g/molN/A
Half-Life~6 hoursApproximately 1 week
Amino AcidsSmall moleculeN/A
Typical DoseTrial-dependent; weekly SC dosing
RouteSubcutaneous
Purity>98%≥98%
Studies Count2814
Research StatusActive ResearchClinical

5-Amino-1MQ Benefits

  • Reduces body fat without appetite changes, lowers cholesterol, increases NAD+ levels, improves metabolic efficiency, supports cellular energy production

Efinopegdutide Benefits

  • reduced body weight
  • improved insulin sensitivity
  • reduced liver fat
  • greater satiety

5-Amino-1MQ Dosing

Research doses: 50-150 mg orally daily. Often cycled 8-12 weeks on, 4 weeks off. Best taken in the morning.

Efinopegdutide Dosing

once-weekly subcutaneous injection|dose escalation during lead-in|maintenance dosing in trials

5-Amino-1MQ Side Effects

  • Generally well-tolerated in preclinical models. Potential mild GI discomfort and headache. Long-term human safety data is limited.

Efinopegdutide Side Effects

  • nausea
  • decreased appetite
  • fatigue

Research Overview

5-Amino-1MQ

Studies in diet-induced obese mice showed significant reductions in body weight, white adipose tissue mass, and cholesterol levels without changes in food intake. Works by inhibiting NNMT enzyme to increase NAD+ and activate sirtuins.

Efinopegdutide

Human trials have shown meaningful weight loss and improvements in hepatic steatosis biomarkers. It remains a research compound with ongoing development in metabolic disease.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

5-Amino-1MQ stacks with:

AOD-9604MOTS-cCJC-1295

Efinopegdutide stacks with:

metforminorlistat
weight-lossNNMT-inhibitorfat-lossmetabolismNAD+glp1glucagondual-agonistobesitynash